Evaluating role of TNF-α in tyrosine kinase inhibitors-treated chronic myeloid leukemia

PurposeChronic Myeloid Leukemia (CML) is characterized by the BCR-ABL1 fusion gene and is effectively managed with tyrosine kinase inhibitors (TKIs). However, therapeutic resistance and the persistence of leukemic stem cells pose challenges to achieving long-term remission. Tumor Necrosis Factor-alp...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Gratial Theres Joseph, Sandeep Kumar Swain, Himanshu Dhanda, Neetu Kushwaha, Priti Kumari, Mahek Pravin Khushalani, Rakesh Kumar, Baseer Noor, Sufian Zaheer, Aditi Jain, Ankur Jain, Sumita Chaudhry, Pranay Tanwar, Amitabh Singh, Bhavika Rishi, Aroonima Misra
Format:	Artigo
Sprog:	Inglês
Udgivet:	Frontiers Media S.A. 2026-02-01
Serier:	Frontiers in Hematology
Fag:	BCR-ABL1 chronic myeloid leukemia (CML) cytokine biomarker ELISA imatinib qRT-PCR
Online adgang:	https://www.frontiersin.org/articles/10.3389/frhem.2026.1709697/full
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!